Responsible Production & the Circular Economy

GreenMoney Journal is pleased announce our Strategic Partnership with Climate & Capital Media - https://www.climateandcapitalmedia.com a global media company that connects investors and entrepreneurs working on climate change solutions.

We believe that only an "engaged investor class" (form Wall Street to Main Street) can prevent a complete collapse of the fragile ecology of our planet, and provide universal dignity to all people around the world...

John Streur, CEO of Calvert introduces GreenMoney readers to China for the first time, stating that “it is preferable for responsible investors to invest in China and engage as shareowners, rather than divest.” I am not sure I agree with him. Do you?

Sustainability is not just a buzzword that companies use to sound “green” — it is fast becoming a core strategic focus.

The Association for Supply Chain Management (ASCM), PYXERA Global, and the Ellen MacArthur Foundation today announced they will work together to help companies become more circular, which will contribute to economic recovery following the pandemic and beyond.

While the globe still reels from the continued impacts of the coronavirus pandemic, other threats loom on the horizon. Indeed, some pundits are reminding us not to lose sight of other crises – including climate change.

Tersano, Inc. announced today its patented Stabilized Aqueous Ozone (SAO®) solution is compliant with the requirements established in the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), to eliminate SARS-CoV-2, the pathogen that causes COVID-19. Tersano’s SAO solution kills over 99.99% of the MHV coronavirus within one minute.

Hallmark Cards, Inc. manufactured and donated 10,000 face shields to the State of Missouri for distribution to healthcare organizations and schools.

Alliant Energy announces completion of its plan to add 1,000 megawatts (MW) of wind production in Iowa, several months ahead of schedule and within budget.

In signing the communiqué, Johnson & Johnson and 15 other life science companies are committing to prioritize the safety, science and accessibility of the potential vaccines, therapeutic medicines or diagnostic tools they are developing to help fight the pandemic.